EyePoint Pharmaceuticals Reports Positive Masked Safety Update for Lead Product Candidate EYP-1901 in Ongoing PAVIA and DAVIO 2 Phase 2 Clinical Trials as of September 1, 2023
– Interim analysis of masked data shows EYP-1901 is well tolerated with no reported drug-related…
UAE-Based The Black Box Announces Project Pipeline Exceeding USD 10 Million Following Participation at Make it in the Emirates 2026
Lerner & Rowe Gives Back to Host 5th Annual Cornhole Tournament on May 9 in Crown Point, Indiana
Sagtec Global Limited Strengthens Smart Property Development Collaboration Following Stateight Sdn Bhd’s Industry Recognition
TruMerit and Credivera Issue First Verifiable Digital Credentials for Global Healthcare Professionals
MK International Achieves ASEAN & Asia Records for Proprietary Quantum Molecular Technology Spray Series